Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis-Reference-Cited by-同舟云学术

Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis

Published:2023 Issue:4 Volume:34 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Su Hao¹^ORCID,Jin Yueqi²^ORCID,Tao Changyu³^ORCID,Yang Hua¹^ORCID,Yang Ence²^ORCID,Zhang Wei-Guang³^ORCID,Feng Fengzhi¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

2. Department of Medical Bioinformatics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

3. Department of Human Anatomy, Histology & Embryology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

Funder

Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences

Natural Science Foundation of Beijing Municipality

Publisher

XMLink

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2023.34.e48

Reference40 articles.

1. Cancer statistics, 2019

2. Challenges and Opportunities in Studying the Epidemiology of Ovarian Cancer Subtypes

3. Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

4. Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review

5. Prognostic implications of tumour-infiltrating lymphocytes for recurrence in epithelial ovarian cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD4+ T cells in antitumor immunity;Trends in Cancer;2024-09

2. Identification of the prognostic value of LACTB2 and its correlation with immune infiltrates in ovarian cancer by integrated bioinformatics analyses;European Journal of Medical Research;2024-03-12

3. MCM2 is involved in subtyping and tamoxifen resistance of ERα‐positive breast cancer by acting as the downstream factor of ERα;Biotechnology Journal;2024-02

4. Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors;International Journal of Molecular Sciences;2023-07-30